Tsung-wen Chen

Taoyuan, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Over-expression of TNNI3K is associated with early-stage carcinogenesis of cholangiocarcinoma.

Over-expression of TNNI3K is associated with early-stage carcinogenesis of cholangiocarcinoma.

Journal: Molecular carcinogenesis
Published: August 07, 2018

Synthesis and evaluation of ortho-[18F] fluorocelecoxib for COX-2 cholangiocarcinoma imaging.

Synthesis and evaluation of ortho-[18F] fluorocelecoxib for COX-2 cholangiocarcinoma imaging.

Journal: Drug design, development and therapy
Published: June 07, 2018

Dataset on the synthesis and characterization of boron fenbufen and its F-18 labeled homolog.

Dataset on the synthesis and characterization of boron fenbufen and its F-18 labeled homolog.

Journal: Data in brief
Published: July 17, 2017

Synthesis and characterization of boron fenbufen and its F-18 labeled homolog for boron neutron capture therapy of COX-2 overexpressed cholangiocarcinoma.

Synthesis and characterization of boron fenbufen and its F-18 labeled homolog for boron neutron capture therapy of COX-2 overexpressed cholangiocarcinoma.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: April 27, 2017

Surgical management of patients with progressing metastatic gastrointestinal stromal tumors receiving sunitinib treatment: A prospective cohort study.

Surgical management of patients with progressing metastatic gastrointestinal stromal tumors receiving sunitinib treatment: A prospective cohort study.

Journal: International journal of surgery (London, England)
Published: October 31, 2016

Peritumoral SPARC expression and patient outcome with resectable intrahepatic cholangiocarcinoma.

Peritumoral SPARC expression and patient outcome with resectable intrahepatic cholangiocarcinoma.

Journal: OncoTargets and therapy
Published: August 08, 2015

Clinical significance of pathological complete response in patients with metastatic gastrointestinal stromal tumors after imatinib mesylate treatment--lessons learned.

Clinical significance of pathological complete response in patients with metastatic gastrointestinal stromal tumors after imatinib mesylate treatment--lessons learned.

Journal: Anticancer research
Published: November 05, 2014

Imatinib escalation or sunitinib treatment after first-line imatinib in metastatic gastrointestinal stromal tumor patients.

Imatinib escalation or sunitinib treatment after first-line imatinib in metastatic gastrointestinal stromal tumor patients.

Journal: Anticancer research
Published: September 10, 2014

Fractioned dose regimen of sunitinib for patients with gastrointestinal stromal tumor: a pharmacokinetic and treatment efficacy study.

Fractioned dose regimen of sunitinib for patients with gastrointestinal stromal tumor: a pharmacokinetic and treatment efficacy study.

Journal: Translational oncology
Published: May 20, 2014

Antitumor activity of the combination of an HSP90 inhibitor and a PI3K/mTOR dual inhibitor against cholangiocarcinoma.

Antitumor activity of the combination of an HSP90 inhibitor and a PI3K/mTOR dual inhibitor against cholangiocarcinoma.

Journal: Oncotarget
Published: May 07, 2014

Fas/Fas ligand mediates keratinocyte death in sunitinib-induced hand-foot skin reaction.

Fas/Fas ligand mediates keratinocyte death in sunitinib-induced hand-foot skin reaction.

Journal: The Journal of investigative dermatology
Published: August 22, 2013

cDNA microarray profiling of rat cholangiocarcinoma induced by thioacetamide.

cDNA microarray profiling of rat cholangiocarcinoma induced by thioacetamide.

Journal: Molecular medicine reports
Published: January 08, 2013
Showing 1-12 of 13

Last Updated: 09/26/2026